Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000675173 | SCV000845331 | pathogenic | Autosomal recessive osteopetrosis 1 | 2018-08-07 | criteria provided, single submitter | clinical testing | |
Centre for Mendelian Genomics, |
RCV000675173 | SCV001369862 | likely pathogenic | Autosomal recessive osteopetrosis 1 | 2018-11-06 | criteria provided, single submitter | clinical testing | This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PM2,PP3,PP5. |
Labcorp Genetics |
RCV001241325 | SCV001414337 | pathogenic | not provided | 2024-06-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln433*) in the TCIRG1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TCIRG1 are known to be pathogenic (PMID: 10888887, 10942435, 11532986, 19448635). This variant is present in population databases (rs777785526, gnomAD 0.02%). This premature translational stop signal has been observed in individuals with osteopetrosis (PMID: 11532986, 15300850). ClinVar contains an entry for this variant (Variation ID: 305804). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000675173 | SCV004205731 | pathogenic | Autosomal recessive osteopetrosis 1 | 2023-11-30 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000675173 | SCV005684255 | pathogenic | Autosomal recessive osteopetrosis 1 | 2024-05-23 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000675173 | SCV000373721 | uncertain significance | Autosomal recessive osteopetrosis 1 | 2017-04-27 | flagged submission | clinical testing | The TCIRG1 c.1297C>T (p.Gln433Ter) is a stop-gained variant that is predicted to result in an elongation of the protein. A literature search was performed for the gene, cDNA change, and amino acid change. No publications were found based on this search. The p.Gln433Ter variant is reported at a frequency of 0.00009 in the European (non-Finnish) population of the Exome Aggregation Consortium. Due to the potential impact of stop-gained variants and the lack of clarifying evidence, the p.Gln433Ter variant is classified as a variant of unknown significance but suspicious for pathogenicity for osteopetrosis. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. |
Counsyl | RCV000675173 | SCV000800796 | pathogenic | Autosomal recessive osteopetrosis 1 | 2017-11-26 | no assertion criteria provided | clinical testing | |
Clinic of Clinical Immunology with Stem Cell Bank, |
RCV000675173 | SCV002573406 | pathogenic | Autosomal recessive osteopetrosis 1 | no assertion criteria provided | clinical testing |